Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title:
Brief Summary: This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Relestat Ophthalmic Solution 0.05% in patients with allergic conjunctivitis who are treated with Relestat as standard of care in clinical practice.